» Authors » Lea Debrut

Lea Debrut

Explore the profile of Lea Debrut including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 28
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Giannini M, Rovito D, Oulad-Abdelghani M, Messaddeq N, Debrut L, Quiring G, et al.
RMD Open . 2025 Mar; 11(1). PMID: 40044571
Introduction: Inflammatory myopathies (IM) are a group of severe autoimmune diseases, sharing some similarities, whose cause is unknown and treatment is empirical.While C-protein-induced myositis (CIM), the most currently used mouse...
2.
Abad C, Pinal-Fernandez I, Guillou C, Bourdenet G, Drouot L, Cosette P, et al.
Nat Commun . 2024 Jun; 15(1):5403. PMID: 38926363
Idiopathic inflammatory myopathies (IIMs) are severe autoimmune diseases with poorly understood pathogenesis and unmet medical needs. Here, we examine the role of interferon γ (IFNγ) using NOD female mice deficient...
3.
Giannini M, Charles A, Evrard C, Blaess J, Bouchard-Marmen M, Debrut L, et al.
Rheumatology (Oxford) . 2024 Mar; 63(9):2503-2514. PMID: 38544289
Objectives: To assess the ability of dual-energy X-ray absorptiometry (DXA) and hand-grip dynamometer to measure damage in inflammatory myopathies (IM). Methods: Forty adult IM patients with a disease duration ≥12 ...
4.
Giannini M, Debrut L, Nespola B, Velten M, Geny B, Sibilia J, et al.
Nat Rev Rheumatol . 2024 Mar; 20(5):311-312. PMID: 38514811
No abstract available.
5.
Charlot A, Bringolf A, Debrut L, Mallard J, Charles A, Crouchet E, et al.
Nutrients . 2024 Mar; 16(5). PMID: 38474774
Weight cycling is a major challenge in obesity management. Caloric restriction is known to promote this phenomenon, but the impact of macronutrient changes during dieting remains unclear. This study aimed...
6.
Debrut L, Giannini M, Klein D, Spielmann L, Mertz P, Martin T, et al.
Arthritis Rheumatol . 2023 May; 75(10):1850-1855. PMID: 37192377
Objective: Inflammatory myopathies (IM), characterized by muscle inflammation and weakness, are rare systemic diseases. Our previous study estimated an IM incidence rate of 7.98 cases per million people per year...
7.
Mallard J, Hucteau E, Bender L, Charlot A, Debrut L, Pflumio C, et al.
Am J Physiol Cell Physiol . 2022 Sep; 323(4):C1325-C1332. PMID: 36094434
Chemotherapy is a common therapy to treat patients with breast cancer but also leads to skeletal muscle deconditioning. Skeletal muscle deconditioning is multifactorial and intermuscular adipose tissue (IMAT) accumulation is...
8.
Levy D, Giannini M, Oulehri W, Riou M, Marcot C, Pizzimenti M, et al.
Nutrients . 2022 Feb; 14(4). PMID: 35215562
Background: The post-COVID-19 condition, defined as COVID-19-related signs and symptoms lasting at least 2 months and persisting more than 3 months after infection, appears now as a public health issue...